RVMD 42.51 ▼ -2.37% Live Trading Data - Stocknear

Revolution Medicines Inc.

NASDAQ: RVMD · Real-Time Price · USD
42.51
-1.03 (-2.37%)
At close: Sep 25, 2025, 3:59 PM
42.41
-0.24%
After-hours: Sep 25, 2025, 05:19 PM EDT
-2.37%
Bid 42
Market Cap 7.95B
Revenue (ttm) n/a
Net Income (ttm) -812.06M
EPS (ttm) -4.52
PE Ratio (ttm) -9.4
Forward PE -7.58
Analyst Buy
Dividends n/a
Ask 45
Volume 1,503,432
Avg. Volume (20D) 2,348,955
Open 43.12
Previous Close 43.54
Day's Range 42.18 - 43.59
52-Week Range 29.17 - 62.40
Beta 1.12
Ex-Dividend Date n/a

About RVMD

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RVMD
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RVMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Revolution Medicines Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+14.31%
Revolution Medicines shares are trading higher aft... Unlock content with Pro Subscription
2 weeks ago
-1.2%
Revolution Medicines shares are trading higher after the company announced daraxonrasib results in metastatic pancreatic cancer and plans to initiate its randomized Phase 3 trial in patients with 1L metastatic PDAC.